Related Experiment Videos
Prognostic factors in primary cutaneous melanoma
Elizabeth Zettersten1, Ladan Shaikh, Raymond Ramirez
1Melanoma Center and Department of Dermatology Cutaneous Oncology Program, Comprehensive Cancer Center, University of California at San Francisco, San Francisco, 1600 Divisadero Street, San Francisco, CA 94115, USA.
The Surgical Clinics of North America
|April 15, 2003
Summary
Melanoma risk assessment improves by considering tumor thickness alongside other factors like ulceration and vascular invasion. This enhances treatment and follow-up strategies for better patient outcomes.
Area of Science:
- Oncology
- Dermatology
- Pathology
Background:
- Tumor thickness is a primary prognostic factor for early-stage melanoma.
- Accurate prognosis is crucial for guiding treatment and follow-up.
Purpose of the Study:
- To evaluate the utility of incorporating additional prognostic indicators beyond tumor thickness for melanoma risk assessment.
- To explore the implications of a probabilistic risk assessment model for treatment selection and patient management.
Main Methods:
- Review of established prognostic indicators in stage I and II melanoma.
- Analysis of the impact of ulceration, vascular invasion, and angiogenesis on patient prognosis.
- Consideration of a probabilistic approach to risk stratification.
Main Results:
- Integrating factors like ulceration, vascular invasion, and angiogenesis refines melanoma prognosis beyond tumor thickness alone.
- Probabilistic risk assessment influences decisions regarding sentinel lymph node biopsy and re-excision margins.
- Risk stratification impacts the selection of appropriate patient follow-up protocols.
Conclusions:
- A multi-factor prognostic model offers a more accurate risk assessment for early-stage melanoma patients.
- Informed risk assessment guides personalized treatment and surveillance strategies.
- Key prognostic factors should be utilized for stratifying patients in adjuvant therapy clinical trials.